Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. (Q47852627)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

B Tang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

E P Böttinger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

S B Jakowlew

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

K M Bagnall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J Mariano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

M R Anver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J J Letterio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

802-807

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9662371%20AND%20SRC:MED&resulttype=core&format=json

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Human Cancer Syndromes: Clues to the Origin and Nature of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Effects of an Rb mutation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Tumor suppressor activity of the TGF-beta pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

Autocrine growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

The type II transforming growth factor-beta receptor as a tumor-suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Altered plasma levels of cytokines in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteop

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Specific and sensitive quantitation of transforming growth factor beta 3 by sandwich enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-802

7 January 2021

https://api.crossref.org/works/10.1038%2FNM0798-802

1 reference

7 January 2021